EVOJECT Trademark

Trademark Overview

On Friday, October 30, 2015, a trademark application was filed for EVOJECT with the United States Patent and Trademark Office. The USPTO has given the EVOJECT trademark a serial number of 86805065. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, October 10, 2016. This trademark is owned by GlaxoSmithKline Intellectual Property Limited. The EVOJECT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
evoject

General Information

Serial Number86805065
Word MarkEVOJECT
Filing DateFriday, October 30, 2015
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, October 10, 2016
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, November 4, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxoSmithKline Intellectual Property Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events

Event DateEvent Description
Tuesday, October 11, 2016ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Monday, October 10, 2016ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, February 29, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, February 29, 2016NON-FINAL ACTION E-MAILED
Monday, February 29, 2016NON-FINAL ACTION WRITTEN
Monday, February 22, 2016ASSIGNED TO EXAMINER
Wednesday, November 4, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, November 3, 2015NEW APPLICATION ENTERED IN TRAM

Related Keywords

evoject pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological